Full Press Release Details
IRVINE, Calif. , Feb. 6, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV ), announced a nationwide open casting call in search of the next Faces of Natrelle ® , encouraging women who have experienced breast reconstruction and/or augmentation to share their inspiring stories and be featured in the brand's upcoming campaign. As an extension of the Natrelle ® For Every BODY platform launched last year, the initiative continues to strengthen the company's commitment to foster an inclusive and diverse space where all women feel seen and valued.
"The Faces of Natrelle ® campaign is more than just celebrating physical beauty," said Carrie Strom , Senior Vice President, AbbVie and President, Global Allergan Aesthetics. "We're honoring the strength, resilience, and uniqueness of the women who use our products. Through this campaign, our goal is to empower women who are considering breast surgery by demystifying treatment, encouraging transparency, and celebrating the diversity of every curve, every shape, and every BODY."
The Faces of Natrelle ® casting call is open now through February 28, 2025 closing at 11:59 p.m. EDT . Women 22 years of age or older who have recently scheduled or undergone a Natrelle ® breast augmentation or reconstruction are encouraged to learn more about eligibility and how to apply at Faces.Natrelle.com . Intended for U.S. audiences only. The final cast will be announced later this year.
To learn more about treatment with Natrelle ® or to find a provider, please visit natrelle.com , and follow along on Instagram @natrellebreastaugmentation and @natrellebreastreconstruction .
*Based on surgeon survey data, January 2021 (N = 114) and Plastics Monthly Tracker DOF Jan. 2021 .
Natrelle ® Breast Implants IMPORTANT SAFETY INFORMATION AND APPROVED USES
Breast implants are not considered lifetime devices. The longer people have them, the greater the chances are that they will develop complications, some of which will require more surgery.
Breast implants have been associated with the development of a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). This cancer occurs more commonly in patients with textured breast implants than smooth implants, although rates are not well defined. Some patients have died from BIA-ALCL.
Patients receiving breast implants have reported a variety of systemic symptoms, such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others. Individual patient risk for developing these symptoms has not been well established. Some patients report complete resolution of symptoms when the implants are removed without replacement.
Who can get breast implants?
Natrelle ® Breast Implants are approved for the following:
Who should NOT get breast implants?
Breast implant surgery should NOT be performed in:
What should I tell my doctor?
Tell your doctor if you have any of the following conditions, as the risks of breast implant surgery may be higher:
What else should I consider?
What are key complications with breast implants? Key complications include reoperation, implant removal with or without replacement, implant rupture with silicone-filled implants, implant deflation with saline-filled implants, and capsular contracture (severe scar tissue around the implant). Other complications include breast pain, swelling, asymmetry, wrinkling/rippling, implant malposition nipple complications, hypertrophic scarring, and implant palpability/visibility.
Talk to your doctor about other complications.
For more information, see the patient brochures at www.allergan.com/products .
To report a problem with Natrelle ® Breast Implants, please call Allergan ® at 1-800-624-4261.
The sale and distribution of Natrelle ® Breast Implants is restricted to licensed physicians who provide information to patients about the risks and benefits of breast implant surgery.
About Allergan Aesthetics At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.allerganaesthetics.com .
About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X (formerly Twitter) , and YouTube.
Allergan Aesthetics Media: Ember Garrett +1 (949) 413-6091 [email protected]
AbbVie Investors:
Liz Shea +1 (847) 935-2211 [email protected]